Industry
Medical - Devices
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products, such as cardiopulmonary and respiratory support solutions. The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. It sells its products through direct sales representatives and independent distributors. The company has a research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
May 02, 2024 | 10:49 am
Portfolio Pulse from Benzinga Newsdesk
May 01, 2024 | 6:46 pm
Portfolio Pulse from Benzinga Newsdesk
May 01, 2024 | 2:41 pm
Portfolio Pulse from Avi Kapoor
May 01, 2024 | 2:27 pm
Portfolio Pulse from Benzinga Newsdesk
May 01, 2024 | 10:10 am
Portfolio Pulse from Benzinga Newsdesk
May 01, 2024 | 10:03 am
Portfolio Pulse from Benzinga Newsdesk
April 25, 2024 | 8:23 pm
Portfolio Pulse from Benzinga Newsdesk
March 27, 2024 | 5:14 pm
Portfolio Pulse from Benzinga Newsdesk
March 20, 2024 | 4:14 pm
Portfolio Pulse from Avi Kapoor
March 20, 2024 | 3:41 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.